India’s Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail ...United Arab Emirates

Gulf News - News
India’s Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail
India’s Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as the country grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials, the drugmaker said, adding it was found to be safe and well-tolerated. The therapy is a cocktail of two monoclonal antibodies, which mimic natural antibodies that the body generates to fight infection. "At this juncture, there is a critical need to explore safer and more efficacious treatments to combat COVID," Zydus Cadila's managing direct

Hence then, the article about india s zydus cadila seeks human trial approval for covid 19 antibody cocktail was published today ( ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( India’s Zydus Cadila seeks human trial approval for COVID-19 antibody cocktail )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News